Please login to the form below

Not currently logged in
Email:
Password:

Bosulif

This page shows the latest Bosulif news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s leukaemia drug Mylotarg backed for use in EU

Pfizer’s leukaemia drug Mylotarg backed for use in EU

Kineret (anakinra) in rare inflammatory condition Still’s disease; and Pfizer’s Bosulif (bosutinib) as a treatment for newly-diagnosed Philadelphia chromosome-positive chronic myelogenous leukaemia (CML).

Latest news

More from news
Approximately 5 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Avillion names Allison Jeynes-Ellis CEO Avillion names Allison Jeynes-Ellis CEO

    candidates. She will now lead Avillion as it prepares to advance its first collaborative development agreement with Pfizer to conduct a global phase III clinical trial evaluating Bosulif (bosutinib) as a

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics